跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
Proposal to distinguish HER2-low from HER2-normal breast cancer by in situ hybridisation
Yen Ying Chen
, Ching Fen Yang, Chih Y. Hsu
衛生福利部雙和醫院
病理學科
研究成果
:
雜誌貢獻
›
文章
›
同行評審
總覽
指紋
指紋
深入研究「Proposal to distinguish HER2-low from HER2-normal breast cancer by in situ hybridisation」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Breast Cancer
100%
in Situ Hybridization
100%
Immunohistochemistry
100%
Neoplasm
22%
Tissue Microarray
22%
Clinical Trial
11%
Malignant Neoplasm
11%
Targeted Therapy
11%
Antibody-Drug Conjugate
11%
Trastuzumab Deruxtecan
11%
Biochemistry, Genetics and Molecular Biology
in Situ Hybridization
100%
Reference Value
33%
Tissue Microarray
33%
Clinical Trial
16%
Gaussian Distribution
16%
Conjugate
16%
Trastuzumab
16%
Immunology and Microbiology
in Situ Hybridization
100%
Reference Value
33%
Antibody Drug Conjugate
16%
Trastuzumab Deruxtecan
16%
Earth and Planetary Sciences
Normal Density Functions
100%